107. 若年性特発性関節炎 Juvenile idiopathic arthritis Clinical trials / Disease details

臨床試験数 : 441 / 薬物数 : 282 - (DrugBank : 56) / 標的遺伝子数 : 52 - 標的パスウェイ数 : 142

63 trials found

diseases per page:

Showing 1 to 10 of 63 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02396212 (ClinicalTrials.gov)	May 7, 2015	25/2/2015	Study of Efficacy and Safety of Canakinumab in Japanese Patients With SJIA	An Open-label, Single-arm, Active-treatment, Efficacy and Safety Study of Canakinumab (ACZ885) Admin ...	Systemic Juvenile Idiopathic Arthritis	Biological: Canakinumab	Novartis Pharmaceuticals	NULL	Completed	2 Years	19 Years	All	19	Phase 3	Japan
2	JPRN-JapicCTI-152865	01/4/2015		Study of Efficacy and Safety of Canakinumab in Japanese Patients With SJIA	An Open-label, Single-arm, Active-treatment, Efficacy and Safety Study of Canakinumab (ACZ885) Admin ...	Systemic Juvenile Idiopathic Arthritis	Intervention name : ACZ885 INN of the intervention : Canakinumab Dosage And administration of the inte ...	Novartis Pharma K.K.	NULL		2	19	BOTH	20	Phase 3	NULL
3	EUCTR2013-004867-29-NL (EUCTR)	23/12/2014	23/09/2014	Study of efficacy and safety of dose reduction or dose interval prolongation of canakinumab in patie ...	An open-label canakinumab (ACZ885) dose reduction or dose interval prolongation efficacy and safety ...	Active systemic manifestations of Systemic Juvenile Idiopathic Arthritis (SJIA) MedDRA version: 19.1 ...	Product Name: canakinumab Product Code: ACZ885 INN or Proposed INN: CANAKINUMAB	Novartis Pharma Services AG	NULL	Not Recruiting			Female: yes Male: yes	180	Phase 3;Phase 4	United States;Hong Kong;Spain;Turkey;Austria;Russian Federation;Israel;Italy;France;Hungary;Mexico;C ...
4	EUCTR2013-004867-29-DE (EUCTR)	28/11/2014	25/08/2014	ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line use of Canakinumab	ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and SafetywIth FIrst-line use of CanakinumabAn op ...	Active systemic manifestations of Systemic Juvenile Idiopathic Arthritis(SJIA) MedDRA version: 19.0; ...	Product Name: canakinumab Product Code: ACZ885 INN or Proposed INN: CANAKINUMAB	Novartis Pharma Services AG	NULL	Not Recruiting			Female: yes Male: yes	180	Phase 3;Phase 4	United States;Hong Kong;Spain;Turkey;Austria;Russian Federation;Israel;Italy;France;Hungary;Mexico;C ...
5	NCT02296424 (ClinicalTrials.gov)	November 17, 2014	10/10/2014	ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line Use of Canakinumab	ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line Use of Canakinumab An ...	Systemic Juvenile Idiopathic Arthritis (SJIA)	Drug: ACZ885 150 mg (Canakinumab)	Novartis Pharmaceuticals	NULL	Completed	2 Years	20 Years	All	182	Phase 3	United States;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;R ...
6	EUCTR2013-004867-29-BE (EUCTR)	07/11/2014	29/09/2014	ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line use of Canakinumab	ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and SafetywIth FIrst-line use of CanakinumabAn op ...	Active systemic manifestations of Systemic Juvenile Idiopathic Arthritis(SJIA) MedDRA version: 18.0; ...	Product Name: canakinumab Product Code: ACZ885 INN or Proposed INN: CANAKINUMAB	Novartis Pharma Services AG	NULL	Not Recruiting			Female: yes Male: yes	180	Phase 3;Phase 4	United States;Hong Kong;Spain;Turkey;Austria;Russian Federation;Israel;Italy;France;Hungary;Mexico;C ...
7	EUCTR2013-004867-29-HU (EUCTR)	04/11/2014	25/08/2014	ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line use of Canakinumab	ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and SafetywIth FIrst-line use of CanakinumabAn op ...	Active systemic manifestations of Systemic Juvenile Idiopathic Arthritis(SJIA) MedDRA version: 18.0; ...	Product Name: canakinumab Product Code: ACZ885 INN or Proposed INN: CANAKINUMAB	Novartis Pharma Services AG	NULL	Not Recruiting			Female: yes Male: yes	180	Phase 3;Phase 4	United States;Hong Kong;Spain;Turkey;Austria;Russian Federation;Israel;Italy;France;Hungary;Mexico;C ...
8	EUCTR2013-004867-29-ES (EUCTR)	20/10/2014	06/08/2014	ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line use of Canakinumab	ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and SafetywIth FIrst-line use of CanakinumabAn op ...	Active systemic manifestations of Systemic Juvenile Idiopathic Arthritis(SJIA) MedDRA version: 17.0; ...	Trade Name: Ilaris Product Name: canakinumab Product Code: ACZ885 INN or Proposed INN: CANAKINUMAB	Novartis Farmacéutica, S.A.	NULL	Not Recruiting			Female: yes Male: yes	180	Phase 3;Phase 4	United States;Hong Kong;Spain;Turkey;Austria;Russian Federation;Israel;Italy;France;Hungary;Mexico;C ...
9	EUCTR2013-004867-29-IT (EUCTR)	03/10/2014	26/08/2014	ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line use of Canakinumab	ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and SafetywIth FIrst-line use of CanakinumabAn op ...	Active systemic manifestations of Systemic Juvenile Idiopathic Arthritis(SJIA) MedDRA version: 17.0; ...	Product Name: canakinumab Product Code: ACZ885 INN or Proposed INN: CANAKINUMAB	NOVARTIS FARMA S.p.A.	NULL	Not Recruiting			Female: yes Male: yes	180	Phase 3;Phase 4	United States;Hong Kong;Spain;Turkey;Austria;Russian Federation;Israel;Italy;France;Hungary;Mexico;C ...
10	EUCTR2014-002872-95-FR (EUCTR)	15/09/2014	18/06/2015	A French extension study of canakinumab in patients with Systemic Juvenile Idiopathic Arthritis who ...	A French open-label extension study of canakinumab in patients with Systemic Juvenile Idiopathic Art ...	Systemic Juvenile Idiopathic Arthritis (SJIA) with active systemic manifestations MedDRA version: 18 ...	Trade Name: ILARIS Product Name: canakinumab Product Code: ACZ885 INN or Proposed INN: CANAKINUMAB	Novartis Pharma S.A.S	NULL	Not Recruiting			Female: yes Male: yes	15	Phase 4	France

First Previous1 2 3 4 5 6 7Next Last